Currently, the share price for Infinium Pharmachem Ltd. is delayed. Login to view live prices.
Infinium Pharmachem Ltd.
₹223.50
NSE
-- ( -- %) 1D
Income Statement
Also called a Profit & Loss statement, an Income Statement shows how a company has performed financially over a specific accounting period. It focuses on revenue, expenses, profits, and losses.
| Particulars (In Cr) | Mar 2024 | Y/Y Change |
|---|---|---|
| Operating Revenue | 135.64 | +18.75% |
| Other Income | 1.54 | +14.07% |
| Total Income | 137.18 | +18.69% |
| Total Expenditure | 121.97 | +18.86% |
| EBIDT | 20.07 | +15.34% |
| Depreciation | 2.67 | +99.25% |
| Interest | 2.19 | -29.35% |
| Tax | 3.71 | +18.15% |
| Net Profit | 11.30 | +19.07% |
Balance Sheet
A financial statement that provides details about a company’s assets, liabilities, and shareholders’ equity at a given point in time.
| Particulars (In Cr) | Mar 2024 | Y/Y Change |
|---|---|---|
| Total Current Assets | 65.01 | +26.70% |
| Total Non-Current Assets | 20.44 | +5.91% |
| Fixed assets | 19.65 | +4.47% |
| Total assets | 85.45 | +21.02% |
| Total Current Liabilities | 17.41 | -52.65% |
| Total Non-Current Liabilities | 7.81 | -22.37% |
| Total Capital Plus Liabilities | 85.45 | +21.02% |
| Total Shareholder Funds | 58.78 | +160.55% |
| Total Debt to Equity | 0.00 | -- |
Cash Flow
The net amount of cash or cash equivalents being transferred in and out of a company for a specified period of time. Cashflow stems from operating, investing and financing activities.
| Particulars (In Cr) | Mar 2024 | Y/Y Change |
|---|---|---|
| Cash from Operating Activity | -13.04 | -251.80% |
| Cash from Financing Activities | 22.77 | -834.52% |
| Cash from Investing Activities | -3.79 | -23.59% |
| Net Cash Flow | 5.93 | +1018.87% |
Trademarks owned by their respective owners and shown here only for ease of recall of the respective owner by public.Disclaimer